User Options
Toggle navigation
Fabric
Login
Register
Login
Register
4194 Objects
About
Browse
Objects
Analytics
Analytics
Research
Contact
Decimal
2 Object Results
Filter results
Add all results to lightbox
Select results to add to lightbox
Sort by:
Date
Title
Sort order:
Ascending
Descending
Start Over
Download results as:
Checklist
PDF (thumbnails)
Excel (basic information)
PowerPoint (basic information)
Add selected results to lightbox
Publication Title:
Food and Drug Administration (FDA)
Evaluation of Automatic Class III Designation (De Novo) for Proteus Personal Monitor Including Ingestion Event Marker
Ingestible Telemetric Gastrointestinal Capsule Imaging System - Final Class II Special Controls Guidance Document for Industry and FDA
Next 36
Filter by
HCI Platform
Ingestible
Discursive Type
A Response to an Invention
An Invention
Persuasive Type
Information
Media Type
Loading...
collection
Policy and Privacy Implications of Ingestibles (2020)
Location on the Body
Abdomen
Digestive tract
Entire body
Skin
Augments
Diagnosing
Monitoring
Observing
Regulating
Testing
Treating
Visualizing
People/Companies/Related Entities
Center For Devices And Radiological Health
Food and Drug Administration (FDA)
Proteus Digital Health
Technology
Biometrics
Digital Pills
Imaging System
Ingestible Capsules
Ingestible Event Marker (IEM) Sensor
Intra-body Communication
Medical Device
Patch
Radiology
Software
Telemetry
Wireless Connectivity
and 5 more
Marketing
Proteus Digital Health
Proteus Personal Monitor
Keyword
Big Pharma
Ethics
Government
Health
Medical
Medication
Patients
Policy
Regulation
Safety
and 3 more
title
Evaluation of Automatic Class III Designation (De Novo) for Proteus Personal Monitor Including Ingestion Event Marker
Ingestible Telemetric Gastrointestinal Capsule Imaging System - Final Class II Special Controls Guidance Document for Industry and FDA
Publication Title
Food and Drug Administration (FDA)